Revenio Group Corporation: FDA marketing approval granted to Icare HOME tonometer in the United States
(WorldNews Finland)

Revenio Group`s subsidiary, Icare Finland Oy has received a marketing approval for the Icare HOME tonometer in the United States. In late November 2016, the company filed a supplemented Premarket Approval application to the United States Food and Drug Administration FDA. The company has now been informed that its PMA application has been accepted. Icare will immediately start preparations for launching the product in the United States. "One of our key goals is to create new treatment practices in which a doctor treating a glaucoma patient, or...